title: Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease.
abstract: Endocrine autoimmune disorders share susceptibility and resistance factors of the human leukocyte antigen system on the short arm of chromosome 6, but other gene loci also contribute to predisposition and protection. Because the cytotoxic T lymphocyte antigen 4 (CTLA4) alanine-17 encoded by the CTLA4 gene on chromosome 2q33 confers susceptibility to Graves' disease, as well as to type 1 (insulin-dependent) diabetes mellitus, we investigated this dimorphism in the other endocrine autoimmune disorders: Hashimoto's thyroiditis and Addison's disease. We analyzed the CTLA4 exon 1 polymorphism (49 A/G) in 73 patients with Hashimoto's thyroiditis, 76 with Addison's disease, and 466 healthy controls. This dimorphism corresponds to an aminoacid exchange (Thr/Ala) in the leader peptide of the expressed protein. CTLA4 alleles were defined by PCR, single-strand conformational polymorphism analysis, and restriction fragment length polymorphism analysis using BbvI. Patients with Hashimoto's thyroiditis had significantly more Ala alleles than controls, both as homozygotes (22% vs. 15%) and heterozygotes (53% vs. 46%), and less Thr than controls as homozygotes (25% vs. 39%), P < 0.04. The phenotypic frequency for Ala was significantly higher in patients (75%), compared with controls (61%), P < 0.03. Patients with Addison's disease did not differ significantly from controls, but those carrying the suceptibility marker, human leukocyte antigen DQA1*0501, were significantly more CTLA4 Ala17 positive than controls with the same DQA1 allele (P < 0.05). In conclusion, an alanine at codon 17 of CTLA4 confers genetic susceptibility to Hashimoto's thyroiditis, whereas this applies only to the subgroup of DQA1*0501+ patients with Addison's disease.
authors.affiliation: Medical Clinic I, Klinikum of the Johann Wolfgang Goethe-University, Frankfurt/Main, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Donner
authors.forename: J
authors.initials: J
authors.lastname: Braun
authors.forename: C
authors.initials: C
authors.lastname: Seidl
authors.forename: H
authors.initials: H
authors.lastname: Rau
authors.forename: R
authors.initials: R
authors.lastname: Finke
authors.forename: M
authors.initials: M
authors.lastname: Ventz
authors.forename: P G
authors.initials: PG
authors.lastname: Walfish
authors.forename: K H
authors.initials: KH
authors.lastname: Usadel
authors.forename: K
authors.initials: K
authors.lastname: Badenhoop
mesh_terms: D000069594:Abatacept; D000224:Addison Disease / Q000276:immunology*; D000293:Adolescent; D000328:Adult; D000483:Alleles; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000235:genetics*; D060908:CTLA-4 Antigen; D003062:Codon / Q000235:genetics*; D005091:Exons / Q000235:genetics; D005787:Gene Frequency; D006683:HLA-DQ Antigens / Q000235:genetics; D006801:Humans; D018796:Immunoconjugates; D011110:Polymorphism, Genetic / Q000235:genetics*; D012016:Reference Values; D013967:Thyroiditis, Autoimmune / Q000276:immunology*
chemical_list: D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D003062:Codon; D006683:HLA-DQ Antigens; D018796:Immunoconjugates; D000069594:Abatacept